Background Chimerism analysis is an important tool for the surveillance of post-transplant
engraftment. It offers the possibility of identifying impending graft rejection and recurrence of …

Recently, we have shown that patients with acute leukaemias and myelodysplastic
syndromes (MDS), who showed increasing mixed chimaerism (MC) upon serial PCR …

In this study, we analysed the chimaeric status of peripheral blood leucocytes (PBLs) in
recipients of allogeneic bone marrow transplantation (BMT) with the use of short tandem …

Using red cell phenotyping (RCP) and/or cytogenetics (CYT) we identified 19 patients with
persisting mixed chimerism (MC) among 231 patients transplanted with partially T cell …

Relapse of chronic myelogenous leukemia after bone marrow transplantation can be
detected by using clinical, cytogenetic, or molecular tools. A modification of the polymerase …

We describe the methodology and application of the polymerase chain reaction to detect
BCR-ABL mRNA as a marker for CML cells. The technique is highly sensitive enabling the …

Increasing mixed chimerism (MC) after allogeneic stem cell transplantation (SCT) has been
associated with a high risk of relapse in acute leukemia. We evaluated a new method for …

We compared the results of chimerism analyses with real‐time SNP‐PCR to those obtained
by the classical STR‐PCR method in 135 hematopoietic stem cell transplantation recipients …

After bone marrow transplantation, recipient hematopoietic cells are usually eradicated by
the combination of the cytotoxic preconditioning regimen and the allogeneic effect of the …

The fate of the leukaemic clone after bone marrow transplantation (BMT) for patients with
chronic myeloid leukaemia (CML) may determine the long-term prognosis. Several groups …